Not connected to GLP3Planner: GLP3Planner has no connection to “GLP3-B” capsules or any shop selling them through social media ads. We don't sell medication, supplements or peptides and never take orders. For an order or refund, contact the seller or your bank or card provider.

Is There a Wegovy Pill? Oral Semaglutide for Weight Loss

Yes. The Wegovy pill is a once-daily 25mg oral semaglutide for weight loss, FDA-approved December 22, 2025. Here is the dose, results, and how to take it.

A single oral semaglutide tablet rests beside a small glass of water on a clinical surface.

Semaglutide · Oral Forms

Is There a Wegovy Pill? The Oral Semaglutide for Weight Loss

If you have searched "is there a Wegovy pill," the answer is yes. The FDA approved an oral Wegovy pill on December 22, 2025: a once-daily 25mg semaglutide tablet for weight management, and it reached US pharmacies in early January 2026. It is the first oral GLP-1 cleared specifically for weight loss, and it sits alongside the familiar once-weekly injection pen rather than replacing it.

Quick Answer

Yes. The Wegovy pill is a once-daily 25mg oral semaglutide tablet, FDA-approved on December 22, 2025 for weight management. Take it first thing after waking on an empty stomach with a small sip of water (up to 4 ounces), then wait 30 minutes before eating. It is a separate product from the diabetes-only Ozempic pill.

Key Takeaways

  • Yes, an oral Wegovy pill exists. A once-daily 25mg semaglutide tablet, FDA-approved on December 22, 2025, the first oral GLP-1 cleared for weight management.
  • The target dose is 25mg once daily, reached by titrating up through 1.5mg, 4mg, and 9mg steps before continuing to 25mg.
  • Take it on an empty stomach with a small sip of plain water, then wait 30 minutes before eating, drinking, or taking other medicines.
  • In the OASIS-4 trial, adults who stayed on treatment lost about 16.6% of their body weight on average, and roughly one in three lost 20% or more.
  • It is not the Ozempic pill. The Ozempic pill (1.5, 4, and 9mg) treats type 2 diabetes only; the Wegovy pill is the weight-management product.
  • The pill and the injection pen are the same molecule in two formats, with different top doses because tablets are absorbed less efficiently than injections.

25 mg

Target dose, once daily

Dec 22, 2025

FDA approval date

16.6%

Mean loss, adherent (OASIS-4)

30 min

Wait before eating

Is There a Wegovy Pill? The Direct Answer

Yes. For years, Wegovy meant a once-weekly injection you self-administered with a pen. That changed at the end of 2025. The FDA approved an oral form of Wegovy on December 22, 2025, and Novo Nordisk began selling it in US pharmacies in early January 2026. It is a tablet you swallow once a day, and it contains the same active ingredient as the pen, semaglutide.

The injectable Wegovy pen has not gone away. Both forms are made by Novo Nordisk, both are sold side by side, and both are approved for the same job: weight management in adults with obesity, or in adults who are overweight and have at least one weight-related health condition. The Wegovy pill also carries an indication to reduce the risk of major cardiovascular events in adults with known heart disease who have obesity or overweight, the same benefit demonstrated for the injectable version.

One point trips up almost everyone who asks this question, so here it is up front. The Wegovy pill is the weight-management product. It is not the same as the Ozempic pill, which shares the semaglutide molecule but is approved only for type 2 diabetes. If your goal is weight loss and you specifically want an oral option, the Wegovy pill is what you are looking for. For the full brand picture, including the injectable pens, see the semaglutide hub.

Wegovy Pill Dose, Titration, and How to Take It

The Wegovy pill's target maintenance dose is 25mg once daily. You do not start there. Prescribers step the dose up gradually to give the stomach time to adjust and to keep nausea in check, titrating through 1.5mg, 4mg, and 9mg before continuing on to the 25mg target. These are the same intermediate strengths used on the diabetes side of oral semaglutide, which is why you may recognize the numbers. Each step is typically held for at least 30 days before moving up.

Dose titration chart with bars rising from 1.5 mg to the 25 mg Wegovy pill target.

The Wegovy pill is titrated up through 1.5, 4, and 9mg steps before continuing to the 25mg maintenance dose.

The empty-stomach rule

Oral semaglutide is fussy about how it is taken, and this is not optional. Take the tablet first thing after waking, on an empty stomach, with no more than a small sip of plain water (about 4 ounces). Then wait at least 30 minutes before you eat, drink anything else, or take other oral medicines. Food and extra liquid in the stomach block absorption, so a tablet taken with breakfast delivers far less drug than one taken correctly. This is the same administration discipline the oral diabetes tablets carry, and it applies to the Wegovy pill every single day.

Model Your Semaglutide Levels

Moving from a weekly pen to a daily tablet changes your dosing rhythm. Plot semaglutide's roughly 7-day half-life and see how a schedule builds to steady state in a free calculator.

Open Semaglutide Calculator →

Wegovy Pill vs. Wegovy Injection (the Pen)

The pill and the pen are the same drug approved for the same indication, so the choice between them is mostly about format and rhythm rather than about what the medicine does. The differences that matter in daily life are dosing frequency, the numbers on the label, and whether you want a needle in the picture at all.

Feature Wegovy pill Wegovy pen
How you take it Swallowed tablet Subcutaneous injection
Frequency Once daily Once weekly
Top dose 25 mg 2.4 mg
Approved for Weight management + cardiovascular risk Weight management + cardiovascular risk

The milligram numbers look wildly different, and there is a reason. Swallowed semaglutide is absorbed far less efficiently than injected semaglutide, so an oral tablet needs a much larger milligram dose to deliver a comparable amount of active drug to the bloodstream. A 25mg tablet is not ten times stronger than a 2.4mg injection; most of an oral dose never makes it past the gut. That lower, more variable absorption is also why the empty-stomach rule is so strict. Neither format is labeled as more effective than the other.

Wegovy pill versus injection: once-daily 25 mg oral tablet beside once-weekly 2.4 mg injection pen.

Same molecule, two formats: a once-daily 25mg tablet and a once-weekly injection pen at a 2.4mg maintenance dose.

How Effective Is the Wegovy Pill? (OASIS-4 Results)

The Wegovy pill was studied in a trial called OASIS-4, which tested the 25mg once-daily tablet in adults with overweight or obesity. In that trial, adults who stayed on treatment lost about 16.6% of their body weight on average, and roughly one in three lost 20% or more. Those results land in the same range as the injectable Wegovy 2.4mg pen, which is the headline reason the pill matters: it offers a needle-free route to weight loss broadly comparable to the established injection.

The "when adhered to" wording is doing real work in that sentence, so keep it. The 16.6% figure describes people who stayed on treatment through the trial. Real-world results depend on dose, consistency with the strict morning routine, and how each person responds, and they vary from one person to the next. The number is an average from a controlled study, not a promise for any individual.

Dr. Tony Hampton, a metabolic-health physician, walks through what the Wegovy pill is, how it is dosed, and how it differs from the injection.

Wegovy Pill vs. Ozempic Pill: the Weight vs. Diabetes Wall

This is where the confusion gets expensive, so read carefully. There are now two oral semaglutide brands, and they are not interchangeable. The Wegovy pill treats obesity. The Ozempic pill treats type 2 diabetes. They share a molecule, but the FDA approved them for different jobs at different doses.

Do not treat the Ozempic pill as a cheaper route to Wegovy-pill weight loss. The Ozempic pill (1.5, 4, and 9mg) is a diabetes medicine and is not approved for weight loss. If you want oral semaglutide for weight management, the approved product is the Wegovy pill at 25mg once daily. Neither substitutes for the other.

So keep the two numbers straight. On the Wegovy pill, 25mg is the maintenance target for weight, and 9mg is only a step along the way. On the Ozempic pill, 9mg is the top diabetes dose. Read both products by indication, not by the milligram number, because the indication is what determines which one a prescriber can write for you. For the diabetes side of oral semaglutide in full, see our guide on whether there is an Ozempic pill. Semaglutide is also the only one of the three GLP-1 molecules we cover with an oral option at all, a contrast we draw out in tirzepatide vs. semaglutide.

Wegovy Pill Cost and How to Get It

The Wegovy pill is a prescription medicine, so the route to it runs through a clinician who agrees it fits your care. There is no legitimate over-the-counter version and no compounded oral equivalent. Because it is brand-name semaglutide from Novo Nordisk, your real out-of-pocket cost is driven by insurance coverage, prior authorization, and any manufacturer savings program you qualify for, and those details shift often.

Rather than trust a figure a friend quoted last year, confirm the current number with your pharmacy and plan. For the full breakdown of list prices, savings cards, insurance, and self-pay routes across the semaglutide lineup, see the semaglutide cost guide.

Who the Wegovy Pill Is (and Isn't) For

The Wegovy pill fits a specific person. It is designed for adults with obesity, or adults who are overweight and have a weight-related condition, who want an oral option instead of a weekly injection. The strict empty-stomach routine every morning is a genuine behavioral commitment, so it suits people who can keep that window consistent.

It is not the right product in several situations. It is not a diabetes-only treatment; that lane belongs to the Ozempic pill. And, consistent with the semaglutide class labeling, it is not for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Anyone who is pregnant, planning pregnancy, or has a history of pancreatitis should raise that with a clinician before starting. Side effects mirror the rest of the GLP-1 class: nausea, diarrhea, vomiting, and constipation are the common ones, usually mild to moderate and most noticeable during dose increases. For the full picture, see semaglutide side effects and the semaglutide dosing guide.

Frequently Asked Questions

Is there a Wegovy pill?

Yes. The FDA approved an oral Wegovy pill on December 22, 2025: a once-daily 25mg semaglutide tablet for weight management. It launched in US pharmacies in early January 2026 and is a separate product from the diabetes-only Ozempic pill.

Is the Wegovy pill effective?

In the OASIS-4 trial, adults who stayed on treatment lost about 16.6% of their body weight on average, and roughly one in three lost 20% or more, results in the same range as the injectable Wegovy 2.4mg pen. Individual results vary by dose, adherence, and response.

What is the Wegovy pill dose?

The Wegovy pill's target maintenance dose is 25mg once daily, reached by titrating up through 1.5mg, 4mg, and 9mg steps before continuing to 25mg. Your prescriber sets the pace, typically holding each step for at least 30 days.

How do you take the Wegovy pill?

Take it first thing after waking, on an empty stomach, with no more than a small sip of plain water (about 4 ounces). Wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines. Food and extra liquid block absorption.

Is the Wegovy pill the same as the Ozempic pill?

No. They share the active ingredient semaglutide but sit in different lanes. The Wegovy pill (up to 25mg) is approved for weight management and cardiovascular risk reduction; the Ozempic pill (1.5, 4, and 9mg) is approved only for type 2 diabetes. Neither substitutes for the other.

How is the Wegovy pill different from the Wegovy injection?

Both are FDA-approved for the same indication and share a mechanism. The pill is a once-daily 25mg tablet; the pen is a once-weekly injection at a 2.4mg maintenance dose (7.2mg maximum). The much higher oral milligram number reflects lower absorption through the gut, not a stronger effect.

How much does the Wegovy pill cost?

Pricing depends on insurance coverage, prior authorization, and manufacturer savings programs, and it shifts often. For current list prices, savings-card terms, and self-pay routes across the semaglutide lineup, see our semaglutide cost guide rather than relying on a figure quoted elsewhere.

What are the Wegovy pill's side effects?

Side effects mirror the rest of the GLP-1 class: nausea, diarrhea, vomiting, and constipation are most common, usually mild to moderate and most noticeable during dose increases. Discuss any persistent or severe symptoms with your prescriber. For the full incidence-by-dose breakdown, the oral-vs-pen comparison, and management strategies, see Wegovy pill side effects.

How do you get the Wegovy pill?

It is a prescription-only medicine, and there is no legitimate over-the-counter version. A clinician evaluates whether an oral or injectable route, and which brand, fits your situation, then prescribes accordingly through a pharmacy.

Can you switch from the Wegovy injection to the Wegovy pill?

Switching between formats is a conversation for your prescriber, since the pill and pen are not dosed on a simple milligram-for-milligram basis and the pill's strict empty-stomach routine is a real commitment. Neither format is labeled as more effective than the other.

Plan Your Semaglutide Schedule

Join 675+ users mapping GLP-1 dosing with the free calculator. Compare a daily tablet against a weekly pen and see the curve before you commit.

References

  1. Novo Nordisk. Wegovy (oral semaglutide 25 mg) approved by the FDA for weight management. Novo Nordisk newsroom; 2025. Novo Nordisk news release.
  2. Wharton S, Lingvay I, Bogdanski P, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS-4). N Engl J Med. 2025;393(11):1077-1087. NEJM.
  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. NEJM.
  4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023;389(24):2221-2232. NEJM.
  5. U.S. Food and Drug Administration. Drugs@FDA: FDA-Approved Drugs (semaglutide, Wegovy labeling). Drugs@FDA database.

Medical Disclaimer: This article is for informational purposes only and does not replace professional medical advice. Semaglutide, in tablet or injectable form, is a prescription medication; take it only under the supervision of a licensed prescriber. Product names, approvals, and dosing reflect information available in mid 2026 and are subject to change. Consult your doctor before starting, stopping, or adjusting any treatment.